Sophia Genetics SA SOPH
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Sophia Genetics SA is a global leader in data-driven medicine focused on enabling healthcare institutions to leverage artificial intelligence and data analytics to enhance clinical diagnosis. The company's main purpose is to democratize data-driven medicine, making genomic and other types of patient data insights acces…
SectorHealthcare
ExchangeNASDAQ
IndustryHealth Information Services
CountrySwitzerland
Employees415
TickerSOPH
Statistics
Market Cap$376.9M
Revenue (TTM)$82.0M
Net Income—
Net Margin—
EPS—
P/E-4.19
P/S4.60
P/B8.18
EV/EBITDA-5.27
ROE-123.3%
Dividend Yield—
Price$5.25
Data: Twelve Data · Revenue = mcap / P/S